Aslan Fred bought ARTV
September 10, 2026 · Form 4 insider transaction
Aslan Fred bought 45,000 shares of Artiva Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
45,000
Price
$0.00
Total value
N/A
InsiderAslan Fred
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 10, 2026
Filing dateSeptember 14, 2026
Shares owned after1,494,765
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.